BSE filing, NSE: BACPHAR. Summary written from the filing by ALFA Finder's alert engine.
Bacil Pharma Ltd: key numbers
- Share price
- ₹18.89
- Market cap
- ₹27.11 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹1.56 Cr
- P/E (TTM)
- 42.9×Sector 48.7×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bacil Pharma Ltd
All →Bacil Pharma Other Announcement
Bacil Pharma Ltd submitted its quarterly shareholding pattern for the period ending September 30, 2026, in compliance with SEBI Regulation 31.
Bacil Pharma Q2 FY27 Results: Net Loss of ₹0.1 Cr
Bacil Pharma Ltd reported a net loss of ₹0.1 Cr for Q2 FY27.
- Key figure
- Net loss ₹0.1 Cr
Bacil Pharma Management Change
Mr. Dikshant Singh Panwar has resigned as Whole-Time Company Secretary and Compliance Officer of Bacil Pharma Limited, effective October 8, 2026.
Bacil Pharma Board Meeting Date
Bacil Pharma will hold a board meeting on October 14, 2026, to consider and approve the unaudited financial results for the quarter and half-year ended September 30, 2026.
Bacil Pharma Annual Report
Bacil Pharma Limited submitted its 39th Annual Report for FY 2025-26. The Annual General Meeting is scheduled for September 23, 2026, via video conferencing.
Bacil Pharma Annual General Meeting
Bacil Pharma Limited has announced book closure dates from September 17 to September 23, 2026, for its 39th Annual General Meeting.
Other capital structure change announcements
All →Rane Holdings Capital Structure Change
Rane Holdings took up 5,15,954 rights shares in its 49%-owned JV, ZF LIFETEC Rane Automotive. No consideration is disclosed, and its stake stays at 49%.
Automobile Corporation Of Goa Capital Structure Change
Automobile Corporation of Goa filed its buyback letter of offer for 1,44,639 shares at Rs 2,005 each. Up to Rs 29.00 Crore tender buyback opens November 3.
- Value
- ₹29.00 Cr
Advanced Enzyme Technologies Capital Structure Change
Advanced Enzyme closed its buyback after purchasing 2,410,906 shares for ₹69.70 Crore. Closure took effect October 30, 2026, ahead of the scheduled period.
- Value
- ₹69.70 Cr
- Execution
- August 14, 2026 to October 30, 2026
Medi Assist Healthcare Services Capital Structure Change
Medi Assist Healthcare's board approved a tender-offer buyback of up to 11,59,199 shares at Rs 425 each, capped at Rs 49.27 Crore. The record date is 20 November 2026, and promoters will not participate.
- Value
- ₹49.27 Cr
KS Smart Technologies Capital Structure Change
KS Smart Technologies called an extraordinary general meeting on 25-Nov-2026 to approve increasing its authorised share capital. The resolution also alters the MoA and AoA clauses.
Bharat Forge Capital Structure Change
Bharat Forge completed a Rs 240 crore rights-issue investment in its wholly owned subsidiary KSSL. KSSL in turn invested Rs 163 crore in its subsidiary AEL.
- Value
- ₹240.0 Cr